352 related articles for article (PubMed ID: 21189327)
21. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development.
Zhang S; Hao J; Xie F; Hu X; Liu C; Tong J; Zhou J; Wu J; Shao C
Carcinogenesis; 2011 Aug; 32(8):1183-9. PubMed ID: 21665894
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer.
Hao J; Zhang S; Zhou Y; Hu X; Shao C
FEBS Lett; 2011 Jan; 585(1):207-13. PubMed ID: 21112326
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer.
Geraldo MV; Yamashita AS; Kimura ET
Oncogene; 2012 Apr; 31(15):1910-22. PubMed ID: 21874046
[TBL] [Abstract][Full Text] [Related]
24. miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer.
Guo X; Guo L; Ji J; Zhang J; Zhang J; Chen X; Cai Q; Li J; Gu Q; Liu B; Zhu Z; Yu Y
Biochem Biophys Res Commun; 2010 Jul; 398(1):1-6. PubMed ID: 20510161
[TBL] [Abstract][Full Text] [Related]
25. Both miR-17-5p and miR-20a alleviate suppressive potential of myeloid-derived suppressor cells by modulating STAT3 expression.
Zhang M; Liu Q; Mi S; Liang X; Zhang Z; Su X; Liu J; Chen Y; Wang M; Zhang Y; Guo F; Zhang Z; Yang R
J Immunol; 2011 Apr; 186(8):4716-24. PubMed ID: 21383238
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
Corney DC; Flesken-Nikitin A; Godwin AK; Wang W; Nikitin AY
Cancer Res; 2007 Sep; 67(18):8433-8. PubMed ID: 17823410
[TBL] [Abstract][Full Text] [Related]
27. The Brm gene suppressed at the post-transcriptional level in various human cell lines is inducible by transient HDAC inhibitor treatment, which exhibits antioncogenic potential.
Yamamichi N; Yamamichi-Nishina M; Mizutani T; Watanabe H; Minoguchi S; Kobayashi N; Kimura S; Ito T; Yahagi N; Ichinose M; Omata M; Iba H
Oncogene; 2005 Aug; 24(35):5471-81. PubMed ID: 16007216
[TBL] [Abstract][Full Text] [Related]
28. Genetic and epigenetic alterations of BRG1 promote oral cancer development.
Gunduz E; Gunduz M; Ouchida M; Nagatsuka H; Beder L; Tsujigiwa H; Fukushima K; Nishizaki K; Shimizu K; Nagai N
Int J Oncol; 2005 Jan; 26(1):201-10. PubMed ID: 15586241
[TBL] [Abstract][Full Text] [Related]
29. miR-199a-5p silencing regulates the unfolded protein response in chronic obstructive pulmonary disease and α1-antitrypsin deficiency.
Hassan T; Carroll TP; Buckley PG; Cummins R; O'Neill SJ; McElvaney NG; Greene CM
Am J Respir Crit Care Med; 2014 Feb; 189(3):263-73. PubMed ID: 24299514
[TBL] [Abstract][Full Text] [Related]
30. p53-facilitated miR-199a-3p regulates somatic cell reprogramming.
Wang J; He Q; Han C; Gu H; Jin L; Li Q; Mei Y; Wu M
Stem Cells; 2012 Jul; 30(7):1405-13. PubMed ID: 22553189
[TBL] [Abstract][Full Text] [Related]
31. Brm transactivates the telomerase reverse transcriptase (TERT) gene and modulates the splicing patterns of its transcripts in concert with p54(nrb).
Ito T; Watanabe H; Yamamichi N; Kondo S; Tando T; Haraguchi T; Mizutani T; Sakurai K; Fujita S; Izumi T; Isobe T; Iba H
Biochem J; 2008 Apr; 411(1):201-9. PubMed ID: 18042045
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of miR-199a-5p decreases esophageal cancer cell proliferation through repression of mitogen-activated protein kinase kinase kinase-11 (MAP3K11).
Byrnes KA; Phatak P; Mansour D; Xiao L; Zou T; Rao JN; Turner DJ; Wang JY; Donahue JM
Oncotarget; 2016 Feb; 7(8):8756-70. PubMed ID: 26717044
[TBL] [Abstract][Full Text] [Related]
33. Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state.
Yamamichi N; Inada K; Ichinose M; Yamamichi-Nishina M; Mizutani T; Watanabe H; Shiogama K; Fujishiro M; Okazaki T; Yahagi N; Haraguchi T; Fujita S; Tsutsumi Y; Omata M; Iba H
Cancer Res; 2007 Nov; 67(22):10727-35. PubMed ID: 18006815
[TBL] [Abstract][Full Text] [Related]
34. Transcription factor Egr1 acts as an upstream regulator of beta-catenin signalling through up-regulation of TCF4 and p300 expression during trans-differentiation of endometrial carcinoma cells.
Saegusa M; Hashimura M; Kuwata T; Hamano M; Watanabe J; Kawaguchi M; Okayasu I
J Pathol; 2008 Dec; 216(4):521-32. PubMed ID: 18798221
[TBL] [Abstract][Full Text] [Related]
35. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells.
Liu M; Lang N; Chen X; Tang Q; Liu S; Huang J; Zheng Y; Bi F
Cancer Lett; 2011 Feb; 301(2):151-60. PubMed ID: 21186079
[TBL] [Abstract][Full Text] [Related]
36. miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2.
Ma Y; Yu S; Zhao W; Lu Z; Chen J
Cancer Lett; 2010 Dec; 298(2):150-8. PubMed ID: 20638779
[TBL] [Abstract][Full Text] [Related]
37. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210.
Zhang GL; Li YX; Zheng SQ; Liu M; Li X; Tang H
Antiviral Res; 2010 Nov; 88(2):169-75. PubMed ID: 20728471
[TBL] [Abstract][Full Text] [Related]
38. BRG1 loss in MiaPaCa2 cells induces an altered cellular morphology and disruption in the organization of the actin cytoskeleton.
Rosson GB; Bartlett C; Reed W; Weissman BE
J Cell Physiol; 2005 Nov; 205(2):286-94. PubMed ID: 15887247
[TBL] [Abstract][Full Text] [Related]
39. Suppression of p21 by c-Myc through members of miR-17 family at the post-transcriptional level.
Wang Z; Liu M; Zhu H; Zhang W; He S; Hu C; Quan L; Bai J; Xu N
Int J Oncol; 2010 Nov; 37(5):1315-21. PubMed ID: 20878079
[TBL] [Abstract][Full Text] [Related]
40. Preliminary validation of ERBB2 expression regulated by miR-548d-3p and miR-559.
Chen H; Sun JG; Cao XW; Ma XG; Xu JP; Luo FK; Chen ZT
Biochem Biophys Res Commun; 2009 Aug; 385(4):596-600. PubMed ID: 19486885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
